Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6Neoplasms 5Breast Neoplasms 3Testicular Neoplasms 2Polycystic Ovary Syndrome 2Sleep Apnea, Obstructive 1Sleep Apnea Syndromes 1Sexuality 1Sexual Dysfunction, Physiological 1Obesity 1Neoplasm Metastasis 1Muscle Weakness 1Multiple Endocrine Neoplasia Type 1 1Motor Activity 1Metabolic Syndrome 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Infertility 1Hypogonadism 1Hot Flashes 1Fatigue 1Dyspareunia 1Arthralgia 1

Interventions

Gemcitabine 74Capecitabine 60Paclitaxel 59Fluorouracil 58Oxaliplatin 57Bevacizumab 51Docetaxel 50Leucovorin 48Nivolumab 40Cisplatin 40Irinotecan 39Carboplatin 37Cetuximab 34pembrolizumab 32Radiosurgery 32Trastuzumab 30Radiotherapy 27Everolimus 24Sorafenib 23Pemetrexed 20Doxorubicin 20Albumin-Bound Paclitaxel 20Ipilimumab 19Cyclophosphamide 19Panitumumab 18Zoledronic Acid 17Lapatinib 17Erlotinib Hydrochloride 17Prednisone 16pazopanib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasm Metastasis × Testosterone × Clear all
NCT00853697 2015-10-30

Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
6 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡